Iatrogenic atrial septal defect following transseptal cardiac interventions

Mohamad Alkhouli; Mohammad Sarraf; Chad J Zack; David R Holmes; Charanjit S Rihal

doi:10.1016/j.ijcard.2016.02.068

Iatrogenic atrial septal defect following transseptal cardiac interventions

Int J Cardiol. 2016 Apr 15:209:142-8. doi: 10.1016/j.ijcard.2016.02.068. Epub 2016 Feb 6.

Authors

Mohamad Alkhouli¹, Mohammad Sarraf¹, Chad J Zack¹, David R Holmes¹, Charanjit S Rihal¹

Affiliation

¹ Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, United States.

PMID: 26894464
DOI: 10.1016/j.ijcard.2016.02.068

Abstract

In the Era of expanding use of transseptal structural heart disease interventions and catheter ablation techniques for atrial fibrillation, there is increasing interest in the iatrogenic atrial septal defect (iASD) often associated with these procedures. The purpose of this review is to summarize the current evidence on the incidence and clinical impact of iASD, to identify possible predictors of persistent iASD, and to propose a standardized method for the detection, follow up and management of iASD.

Keywords: Iatrogenic atrial septal defect; Pulmonary vein ablation; Structural heart interventions; Transseptal puncture.

Publication types

Review

MeSH terms

Atrial Fibrillation / surgery
Cardiac Surgical Procedures / adverse effects
Cardiac Surgical Procedures / methods
Cardiac Surgical Procedures / statistics & numerical data*
Catheter Ablation / adverse effects
Catheter Ablation / statistics & numerical data
Heart Septal Defects, Atrial / epidemiology*
Heart Septal Defects, Atrial / surgery
Heart Septum / surgery*
Humans
Iatrogenic Disease / epidemiology
Incidence